Canada markets open in 2 hours 25 minutes

Marvel Biosciences Corp. (MRVL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1400-0.0050 (-3.45%)
At close: 02:10PM EST
Full screen
Loading interactive chart...
  • Baystreet

    Stocks in play: Marvel Biosciences Corp

    Announces that Mr. Babak Pedram has joined its Board of Directors. Mr. Pedram is a seasoned capital ...

  • Newsfile

    Marvel Biosciences Announces Director Appointment and Resignation

    Calgary, Alberta--(Newsfile Corp. - November 24, 2022) - Marvel Biosciences Inc. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to announce that, effective November 23, 2022, Mr. Babak Pedram has joined its Board of Directors.Babak Pedram, DirectorMr. Pedram brings a vast degree of business, capital markets and scientific experience to Marvel's Board of Directors. He is a seasoned capital market professional with over

  • Newsfile

    Marvel Biosciences' Lead Drug Candidate MB-204 Demonstrates a 400% Increase in the Survival Rate of Animals Treated with a High Dose of the Cancer Treatment Cis-Platinum

    Calgary, Alberta--(Newsfile Corp. - November 22, 2022) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to announce that in a recent study done by the Company, its lead drug candidate MB-204 demonstrated a 400% increase in the survival rate of animals being treated by high doses of chemotherapy treatment, cis-platinum."We are seeing great momentum being built around our lead drug candidate ...